|
|
Surfactant Protein-D Is Essential for Immunity to Helminth Infection
|
|
|
|
|
نویسنده
|
thawer s. ,auret j. ,schnoeller c. ,chetty a. ,smith k. ,darby m. ,roberts l. ,mackay r.-m. ,whitwell h.j. ,timms j.f. ,madsen j. ,selkirk m.e. ,brombacher f. ,clark h.w. ,horsnell w.g.c.
|
منبع
|
plos pathogens - 2016 - دوره : 12 - شماره : 2
|
چکیده
|
Pulmonary epithelial cell responses can enhance type 2 immunity and contribute to control of nematode infections. an important epithelial product is the collectin surfactant protein d (sp-d). we found that sp-d concentrations increased in the lung following nippostrongylus brasiliensis infection; this increase was dependent on key components of the type 2 immune response. we carried out loss and gain of function studies of sp-d to establish if sp-d was required for optimal immunity to the parasite. n. brasiliensis infection of sp-d-/- mice resulted in profound impairment of host innate immunity and ability to resolve infection. raising pulmonary sp-d levels prior to infection enhanced parasite expulsion and type 2 immune responses,including increased numbers of il-13 producing type 2 innate lymphoid cells (ilc2),elevated expression of markers of alternative activation by alveolar macrophages (alvm) and increased production of the type 2 cytokines il-4 and il-13. adoptive transfer of alvm from sp-d-treated parasite infected mice into naïve recipients enhanced immunity to n. brasiliensis. protection was associated with selective binding by the sp-d carbohydrate recognition domain (crd) to l4 parasites to enhance their killing by alvm. these findings are the first demonstration that the collectin sp-d is an essential component of host innate immunity to helminths. © 2016 thawer et al.
|
|
|
آدرس
|
institute of infectious disease and molecular medicine,international centre for genetic engineering and biotechnology and division of immunology,university of cape town,cape town, South Africa, institute of infectious disease and molecular medicine,international centre for genetic engineering and biotechnology and division of immunology,university of cape town,cape town, South Africa, department of life sciences,imperial college london,london, United Kingdom, institute of infectious disease and molecular medicine,international centre for genetic engineering and biotechnology and division of immunology,university of cape town,cape town, South Africa, institute of infectious disease and molecular medicine,international centre for genetic engineering and biotechnology and division of immunology,university of cape town,cape town,south africa,institute of infection and immunity,university of cardiff,cardiff, United Kingdom, institute of infectious disease and molecular medicine,international centre for genetic engineering and biotechnology and division of immunology,university of cape town,cape town, South Africa, department of life sciences,imperial college london,london, United Kingdom, clinical & experimental sciences academic unit,southampton general hospital,university of southampton,southampton, United Kingdom, cancer proteomics,institute for women’s health,university college london,london, United Kingdom, cancer proteomics,institute for women’s health,university college london,london, United Kingdom, clinical & experimental sciences academic unit,southampton general hospital,university of southampton,southampton, United Kingdom, department of life sciences,imperial college london,london, United Kingdom, institute of infectious disease and molecular medicine,international centre for genetic engineering and biotechnology and division of immunology,university of cape town,cape town, South Africa, clinical & experimental sciences academic unit,southampton general hospital,university of southampton,southampton, United Kingdom, institute of infectious disease and molecular medicine,international centre for genetic engineering and biotechnology and division of immunology,university of cape town,cape town, South Africa
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|